Joseph Carusone

This profile gathers the share dealings of Joseph Carusone in OncBioMune Pharmaceuticals, Inc. We count 9 filings; the first trade dates from 5 November 2008 and the latest from 10 March 2015.

Market trades split into 3 purchases (€44k) and 5 sales (€60k). Netting one side against the other leaves €16k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2015, the count stands at no purchases and 2 sales.

In size, the median ticket on the buying side is €7,426.

Most recently, on 18 March 2015, the filings show an open-market sale worth €194 in OncBioMune Pharmaceuticals, Inc. The last purchase on record was published on 8 April 2013, which is 4,962 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.